Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Semaphorin 3E ELISA Kit (AC2700)
Cat.#: ASET-1289
Specifications
Description Human Semaphorin 3E ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Semaphorin 3E concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 6.39 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1456 Mouse Integrin beta 1 ELISA Kit (AC2867) Quantitative inquiry ASET-1334 Human CX3CR1 ELISA Kit (AC2745) Quantitative inquiry ASET-1373 Human Laminin 2 alpha ELISA Kit (AC2784) Quantitative inquiry ASET-1970 Human OPA1 ELISA Kit (AC3381) Quantitative inquiry ASET-1085 Sheep Leptin ELISA Kit (AC2496) Quantitative inquiry ASET-2454 Human LAR ELISA Kit (AC3865) Quantitative inquiry ASET-1007 Human MT3 ELISA Kit (AC2418) Quantitative inquiry ASET-1592 Human Calnexin ELISA Kit (AC3003) Quantitative inquiry ASET-2541 Human CD133 ELISA Kit (AC3952) Quantitative inquiry ASET-2191 Rat SNAP25 ELISA Kit (AC3602) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket